4//SEC Filing
Nash Huw M. 4
Accession 0001415889-24-019169
CIK 0001623526other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:13 PM ET
Size
7.2 KB
Accession
0001415889-24-019169
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Sale
Common Stock
2024-07-02$13.90/sh−33$459→ 0 total - Sale
Common Stock
2024-07-02$13.10/sh−2,467$32,320→ 33 total
Footnotes (3)
- [F1]The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.83 to $13.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares sold in the reported transactions include an aggregate 2,500 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001780085
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:13 PM ET
- Size
- 7.2 KB